Psychiatric Medication Spending Growth Slows, According to New Thomson Reuters Research

Psychiatric Medication Spending Growth Slows, According to New Thomson Reuters Research - MarketWatch:

WASHINGTON, Feb. 1, 2012 /PRNewswire via COMTEX/ -- The national growth rate for psychiatric medication spending has declined significantly, according to a new study conducted by researchers from Thomson Reuters (Healthcare) and the Substance Abuse and Mental Health Services Administration (SAMHSA).